MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Expanding the reach of a telehealth psychotherapy hub to advance coordinated depression care for rural veterans with Parkinson’s Disease

    J. Mack, L. Marsh, A. Sarwar, K. Rodriguez, A. King, M. Hinojosa-Lindsey, R. Miller, L. ST. Hill, S. O'Connor, K. Ketchum, M. Latorre, A. Interian, R. Dobkin (Portland, USA)

    Objective: To describe the ongoing implementation and expansion of a telehealth psychotherapy hub to treat depression in rural Veterans with PD. Background: Depression is common…
  • 2023 International Congress

    Iron deposition and volume change of deep grey matter nuclei in PARK14 by Quantitative Susceptibility Mapping

    C. Chen, X. Liu, F. Liu, Y. Sun, J. Wang (Shanghai, China)

    Objective: PLA2G6 is the causative gene for autosomal recessive Dystonia-Parkinsonism (PARK14). The aim of this study was to explore the characteristics of iron deposition within…
  • 2023 International Congress

    Genetic outcomes of South Asian Parkinsonism cohort: from a tertiary care hospital

    P. Paramanandam, A. S, A. Deenadayalu, I. N, K. Gowrishankar, T. Koshy (Chennai, India)

    Objective: To identify the genetic heterogeneity in 16 south Asian patient with Parkinson’s disease. Background: Parkinson’s disease(PD) is the second most progressive neurodegenerative disorder with…
  • 2023 International Congress

    Transition among HD-ISS stages as an endpoint in clinical trials for HD

    J. Mills, J. Long, J. Vaidya, S. Sathe, C. Sampaio, S. Tabrizi (Iowa City, USA)

    Objective: Investigate the time to the event of HD-ISS Stage 3 transition (functional change) as an endpoint for clinical trials in Huntington’s disease (HD) and…
  • 2023 International Congress

    Deep Brain Stimulation for Multiple Sclerosis Tremors: A Case Series

    P. Gyawali, F. Farrokhi, M. Marsans, J. Roberts (Seattle, USA)

    Objective: The objective of our study is to report the evidence on the effectiveness and safety of Deep Brain Stimulation (DBS) in managing upper extremity…
  • 2023 International Congress

    White matter lesion burden is associated with poorer clinical and driving outcomes in mild Parkinson’s disease

    E. Uc, V. Magnotta, D. Mcgehee, E. Axelson, M. Mani, J. Dawson, A. Comellas, J. Kline, N. Narayanan, S. Anderson, C. Weber, W. Darling (Iowa City, USA)

    Objective: To determine association of brain white matter microvascular lesion burden with cognition, motor function, and driving in mild Parkinson’s disease (PD). Background: Brain white…
  • 2023 International Congress

    A cross regional investigation into the effects of fractures on the quality of life for elderly people with Parkinson’s disease in rural India

    S. Kuanar, C. Mahapatra (Bhubaneswar, India)

    Objective: The negative impact of Parkinson’s Disease (PD) is rising as the global population ages and fractures with PD are additional health burdens. In rural…
  • 2023 International Congress

    CSF tau reflects long-term outcome of patients with idiopathic normal pressure hydrocephalus: a longitudinal retrospective study.

    J. Bissacco, C. Simonetta, D. Mascioli, N. Mercuri, T. Schirinzi (Roma, Italy)

    Objective: To predict long-term clinical outcome of iNPH patients through a panel of neurodegeneration-related CSF biomarkers. Background: Idiopathic normal pressure hydrocephalus (iNPH) is a neurodegenerative…
  • 2023 International Congress

    The effects of dopaminergic treatment on interhemispheric disinhibition and bradykinesia asymmetry in Parkinson’s disease

    M. de Riggi, G. Paparella, M. Bologna, D. Colella, A. Cannavacciuolo, A. de Biase, D. Birreci, D. Costa, A. Guerra, A. Berardelli (Rome, Italy)

    Objective: to investigate whether dopaminergic therapy modulates IHI and bradykinesia asymmetry in PD. Background: previous evidence demonstrated a reduced interhemispheric inhibition (IHI) in Parkinson’s disease…
  • 2023 International Congress

    Rapidly progressive dementia – catatonia – myoclonus in 80 years old patient: An unusual case

    DAN. Rebolledo Garcia, ART. Cadena Fernandez, ANA. Michel Chavez, JUA. Calderon Martinez, HOR. Senties Madrid, GRI. Romero Sanchez (Mexico City, Mexico)

    Objective: Objective:Sporadic Creutzfeldt-Jakob Disease (sCJD) will be challenging to differentiate from other diseases, like NMDA autoimmune encephalitis (AE). The classic rapidly progressive dementia phenotype that…
  • « Previous Page
  • 1
  • …
  • 332
  • 333
  • 334
  • 335
  • 336
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley